English
  • Warning: Illegal string offset 'stockName' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Warning: Illegal string offset 'NSEcode' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Undefined index: current_date in Drupal\futures_option\Controller\FuturesController->getOptionData() (line 398 of modules/custom/futures_option/src/Controller/FuturesController.php).
  • Warning: array_column() expects parameter 1 to be array, string given in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 33 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: array_multisort(): Argument #1 is expected to be an array or a sort flag in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 34 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: array_slice() expects parameter 1 to be array, string given in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 36 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: Invalid argument supplied for foreach() in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 52 of modules/custom/five_paisa/src/MFHoldingService.php).
  1. Home
  2. Stocks
  3. Remus Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Remus Pharmaceuticals

    Small Cap
    ₹2,047.15
    +129.4 (6.75%)
    29 June, 2024 02:33 BSE: NSE: REMUSISIN: INE0O5T01011
    Bonus

    Start SIP in Remus Pharmaceuticals

    Start SIP

    Remus Pharmaceuticals Performance

    Day Range

    • Low 1,910
    • High 2,130
    ₹ 2,047

    52 Week Range

    • Low 758
    • High 2,300
    ₹ 2,047
    • Open Price1,950
    • Previous Close1,918
    • Volume50900

    Remus Pharmaceuticals Share Price

    • Over 1 Month +11%
    • Over 3 Month +34.03%
    • Over 6 Month +11.75%
    • Over 1 Year +152.39%

    Remus Pharmaceuticals Key Statistics

    P/E Ratio
    PEG Ratio
    Market Cap Cr 1,206
    Price to Book Ratio 11.6
    EPS 28.5
    Dividend 0.1
    Relative Strength Index 56.8
    Money Flow Index 59.8
    MACD Signal 31.65
    Average True Range 133.74
    Remus Pharmaceuticals Financials
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 6747
    Operating Expenses Annual Cr 4334
    Operating Profit Annual in Cr 2011
    Depreciation Cr 10
    Interest Annual Cr 00
    Tax Annual Cr 63
    Net Profit Annual Cr 179
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 25
    Cash from Investing Activity Annual Cr -21-15
    Cash from Financing Annual Activity Cr 3912
    Net Cash Flow Annual Cr 2
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 8219
    Fixed Assets Annual Cr 23
    Total Non Current Assets Annual Cr 4723
    Total Current Assets Annual Cr 5111
    Total Assets Annual Cr 9835
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 557176
    ROE Annual % 2044
    ROCE Annual % 2744
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 3727
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 218
    Operating Expenses Annual Cr 185
    Operating Profit Annual in Cr 28
    Depreciation Cr 1
    Interest Annual Cr 0
    Tax Annual Cr 6
    Net Profit Annual Cr 22
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr 4
    Cash from Investing Activity Annual Cr -9
    Cash from Financing Annual Activity Cr 24
    Net Cash Flow Annual Cr 19
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 87
    Fixed Assets Annual Cr 2
    Total Non Current Assets Annual Cr 48
    Total Current Assets Annual Cr 210
    Total Assets Annual Cr 257
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 708
    ROE Annual % 25
    ROCE Annual % 30
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 16
    Invest in Remus Pharmaceuticals

    Remus Pharmaceuticals Technicals

    EMA & SMA

    Current Price
    ₹2,047.15
    +129.4 (6.75%)
    pointer
    • Bullish Moving Average
    • ___
    • 16
    • Bearish Moving Average
    • ___
    • 0
    • 20 Day
    • ₹1,951.40
    • 50 Day
    • ₹1,876.94
    • 100 Day
    • ₹1,762.07
    • 200 Day
    • ₹1,545.54
    • 20 Day
    • ₹1,964.68
    • 50 Day
    • ₹1,900.52
    • 100 Day
    • ₹1,728.90
    • 200 Day
    • ₹1,577.11

    Remus Pharmaceuticals Resistance and Support

    PIVOT
    ₹2,029.05
    Resistance
    First Resistance 2,148.10
    Second Resistance 2,249.05
    Third Resistance 2,368.10
    RSI 56.80
    MFI 59.80
    MACD Single Line 31.65
    MACD 20.33
    Support
    First Support 1,928.10
    Second Support 1,809.05
    Third Supoort 1,708.10

    Remus Pharmaceuticals Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 50,900 3,310,027 65.03
    Week 16,000 1,048,000 65.5
    1 Month 7,333 475,933 64.9
    6 Month 3,751 247,406 65.95

    Remus Pharmaceuticals Result Highlights

    Remus Pharmaceuticals Synopsis

    NSE-Medical-Whlsle Drg/Suppl

    Remus Pharmaceutic belongs to the Industry of Pharmaceuticals. Company’s Total Operating Revenue is Rs. 45.03 Cr. and Equity Capital is Rs. 1.09 Cr. for the Year ended 31/03/2023. Remus Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 21/09/2015 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is U24232GJ2015PLC084536 and registration number is 084536.
    Market Cap 1,130
    Sales 63
    Shares in Float 0.17
    No of funds 3
    Yield 0.08
    Book Value 13.82
    U/D Vol ratio 1
    LTDebt / Equity 1
    Alpha 0.52
    Beta 1.49

    Remus Pharmaceuticals Shareholding Pattern

    Owner NameMar-24Sep-23
    Promoters 70.6%69.61%
    Foreign Portfolio Investors 3.25%2.38%
    Individual Investors 20.54%21.15%
    Others 5.61%6.86%

    Remus Pharmaceuticals Management

    Name Designation
    Mr. Swapnil Jatinbhai Shah Chairman & Wholetime Director
    Mr. Arpit Deepakkumar Shah Managing Director
    Mrs. Anar Swapnil Shah Whole Time Director
    Ms. Roma Vinodbhai Shah Whole Time Director
    Mr. Balwant Purohit Independent Director
    Mrs. Sanjana Sanjeev Shah Independent Director
    Mr. Vishrut Chandramauli Pathak Independent Director

    Remus Pharmaceuticals Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Remus Pharmaceuticals Corporate Action

    Date Purpose Remarks
    2024-05-16 Audited Results
    2024-04-23 Bonus issue & Interim Dividend
    2024-04-22 Interim Dividend
    Date Purpose Remarks
    2024-05-02 INTERIM Rs.0.00 2nd interim dividend of Rs. 4.00/- (Rupees Four only) per equity share having face value of Rs. 10/- each for the financial year 2023-24.
    2023-10-28 INTERIM Rs.0.00 Interim Dividend of Rs. 2 per equity share.
    Date Purpose Remarks
    2024-06-06 Bonus Rs.0.00 issue in the ratio of 3:1 of Rs. 10/-.

    Remus Pharmaceuticals MF Shareholding

    Name Amount(cr)

    Remus Pharmaceuticals FAQs

    What is Share Price of Remus Pharmaceuticals ?

    Remus Pharmaceuticals share price is ₹2,047 As on 29 June, 2024 | 02:19

    What is the Market Cap of Remus Pharmaceuticals ?

    The Market Cap of Remus Pharmaceuticals is ₹1206.2 Cr As on 29 June, 2024 | 02:19

    What is the P/E ratio of Remus Pharmaceuticals ?

    The P/E ratio of Remus Pharmaceuticals is As on 29 June, 2024 | 02:19

    What is the PB ratio of Remus Pharmaceuticals ?

    The PB ratio of Remus Pharmaceuticals is 11.6 As on 29 June, 2024 | 02:19

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.